Literature DB >> 31486992

Whole exome sequencing in familial isolated primary hyperparathyroidism.

F Cetani1, E Pardi2, P Aretini3, F Saponaro2, S Borsari2, L Mazoni2, M Apicella2, P Civita3, M La Ferla3, M A Caligo4, F Lessi3, C M Mazzanti3, L Torregossa5, A Oppo6, C Marcocci2.   

Abstract

PURPOSE: Familial isolated hyperparathyroidism (FIHP) is a rare inherited disease accounting for 1% of all cases of primary hyperparathyroidism (PHPT). It is genetically heterogeneous being associated with mutations in different genes, including MEN1, CDC73, CASR, and recently GCM2. The aim of the study was to further investigate the molecular pathogenesis in Italian FIHP kindreds.
METHODS: We used whole exome sequencing (WES) in the probands of seven unrelated FIHP kindreds. We carried out a separate family-based exome analysis in a large family characterized by the co-occurrence of PHPT with multiple tumors apparently unrelated to the disease. Selected variants were also screened in 18 additional FIHP kindreds. The clinical, biochemical, and pathological characteristics of the families were also investigated.
RESULTS: Three different variants in GCM2 gene were found in two families, but only one (p.Tyr394Ser), already been shown to be pathogenic in vitro, segregated with the disease. Six probands carried seven heterozygous missense mutations segregating with the disease in the FAT3, PARK2, HDAC4, ITPR2 and TBCE genes. A genetic variant in the APC gene co-segregating with PHPT (p.Val530Ala) was detected in a family whose affected relatives had additional tumors, including colonic polyposis.
CONCLUSION: We confirm the role of GCM2 germline mutations in the pathogenesis of FIHP, although at a lower rate than in the previous WES study. Further studies are needed to establish the prevalence and the role in the predisposition to FIHP of the novel variants in additional genes.

Entities:  

Keywords:  APC; CDC73; Familial adenomatous polyposis; GCM2; PARK2; Primary hyperparathyroidism

Mesh:

Year:  2019        PMID: 31486992     DOI: 10.1007/s40618-019-01107-5

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  50 in total

1.  Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.

Authors:  Aaliyah Riccardi; Tori Aspir; Lilia Shen; Chia-Ling Kuo; Taylor C Brown; Reju Korah; Timothy D Murtha; Justin Bellizzi; Kourosh Parham; Tobias Carling; Jessica Costa-Guda; Andrew Arnold
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

2.  A recurrent mutation in PARK2 is associated with familial lung cancer.

Authors:  Donghai Xiong; Yian Wang; Elena Kupert; Claire Simpson; Susan M Pinney; Colette R Gaba; Diptasri Mandal; Ann G Schwartz; Ping Yang; Mariza de Andrade; Claudio Pikielny; Jinyoung Byun; Yafang Li; Dwight Stambolian; Margaret R Spitz; Yanhong Liu; Christopher I Amos; Joan E Bailey-Wilson; Marshall Anderson; Ming You
Journal:  Am J Hum Genet       Date:  2015-01-29       Impact factor: 11.025

3.  Familial adenomatous polyposis associated with multiple endocrine neoplasia type 1-related tumors and thyroid carcinoma: a case report with clinicopathologic and molecular analyses.

Authors:  Yuzo Sakai; Koich Koizumi; Iwao Sugitani; Ken Nakagawa; Masami Arai; Joji Utsunomiya; Tetsuichiro Muto; Rikiya Fujita; Yo Kato
Journal:  Am J Surg Pathol       Date:  2002-01       Impact factor: 6.394

Review 4.  Parathyroid development and the role of tubulin chaperone E.

Authors:  Ruti Parvari; George A Diaz; Eli Hershkovitz
Journal:  Horm Res       Date:  2006-09-27

5.  Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure.

Authors:  Mustapha El Lakis; Pavel Nockel; Bin Guan; Sunita Agarwal; James Welch; William F Simonds; Stephen Marx; Yulong Li; Naris Nilubol; Dhaval Patel; Lily Yang; Roxanne Merkel; Electron Kebebew
Journal:  Surgery       Date:  2017-11-03       Impact factor: 3.982

6.  Illegitimate WNT pathway activation by beta-catenin mutation or autocrine stimulation in T-cell malignancies.

Authors:  Richard W J Groen; Monique E C M Oud; Esther J M Schilder-Tol; Marije B Overdijk; Derk ten Berge; Roel Nusse; Marcel Spaargaren; Steven T Pals
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

7.  Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study.

Authors:  C Soravia; S L Sugg; T Berk; A Mitri; H Cheng; S Gallinger; Z Cohen; S L Asa; B V Bapat
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

8.  Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features.

Authors:  Elena Pardi; Simona Borsari; Federica Saponaro; Fausto Bogazzi; Claudio Urbani; Stefano Mariotti; Francesca Pigliaru; Chiara Satta; Fabiana Pani; Gabriele Materazzi; Paolo Miccoli; Lorena Grantaliano; Claudio Marcocci; Filomena Cetani
Journal:  PLoS One       Date:  2017-10-16       Impact factor: 3.240

9.  The impact of hereditary cancer gene panels on clinical care and lessons learned.

Authors:  Volkan Okur; Wendy K Chung
Journal:  Cold Spring Harb Mol Case Stud       Date:  2017-11-21

Review 10.  Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.

Authors:  Luís Cardoso; Mark Stevenson; Rajesh V Thakker
Journal:  Hum Mutat       Date:  2017-09-25       Impact factor: 4.878

View more
  5 in total

Review 1.  Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing.

Authors:  Hye-Sun Park; Yeon Hee Lee; Namki Hong; Dongju Won; Yumie Rhee
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-28       Impact factor: 6.055

Review 2.  Familial Hyperparathyroidism.

Authors:  Jenny E Blau; William F Simonds
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

3.  Whole-Exome Sequencing Implicates the USP34 rs777591A > G Intron Variant in Chronic Obstructive Pulmonary Disease in a Kashi Cohort.

Authors:  Jingran Xu; Li Li; Jie Ren; Xuemei Zhong; Chengxin Xie; Aifang Zheng; Ayiguzali Abudukadier; Maimaitiaili Tuerxun; Sujie Zhang; Lifeng Tang; Dilare Hairoula; Xiaoguang Zou
Journal:  Front Cell Dev Biol       Date:  2022-02-07

Review 4.  Clinical and Molecular Genetics of Primary Hyperparathyroidism.

Authors:  William F Simonds
Journal:  Horm Metab Res       Date:  2020-03-30       Impact factor: 2.788

5.  Disease-associated mutations in inositol 1,4,5-trisphosphate receptor subunits impair channel function.

Authors:  Lara E Terry; Kamil J Alzayady; Amanda M Wahl; Sundeep Malik; David I Yule
Journal:  J Biol Chem       Date:  2020-10-22       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.